Insider · CIK 0002058704
Anh Tu Nguyen
Files at XERS (Xeris Biopharma Holdings, Inc.). First filing -, latest -.
In brief
Anh Tu Nguyen files SEC Form 4 as officer at XERS (Xeris Biopharma Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anh Tu Nguyen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | XERS Xeris Biopharma Holdings, Inc. | FTax withholding Common Stock | -29,300 | $6.88 | $202k | 395,023 | Feb 25, 2026 |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | AGrant or award Common Stock | +121,293 | $0.00 | $0 | 424,323 | Feb 2, 2026 |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +162,162 | $0.00 | $0 | 162,162 | Feb 2, 2026 |
Questions about Anh Tu Nguyen
Answered from the filings on this page, as of the latest one.
Is Anh Tu Nguyen buying or selling?
Anh Tu Nguyen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anh Tu Nguyen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anh Tu Nguyen has 0.
Where does Anh Tu Nguyen file Form 4?
Anh Tu Nguyen has filed Form 4 at XERS (Xeris Biopharma Holdings, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.